Nov 2011 Newsletter

 
 

                                              

 

 


Dr. Eitan Yudilevich
Executive Director  


November 2011


An emerging sector to watch: Neurotechnology

Entrepreneurship requires a constant search for opportunities to innovate and pursue new avenues that can make a difference both socially and economically. In recent years, there has been a sense of awakening in a field that has mostly been part of the realm of scientific and academic research: Neuroscience.

Entrepreneurship requires a constant search for opportunities to innovate and pursue new avenues that can make a difference both socially and economically. In recent years, there has been a sense of awakening in a field that has mostly been part of the realm of scientific and academic research: Neuroscience.

Neuroscience has given rise to Neurotechnology. The know-how created by scientists in the academic world is gradually reaching maturity, allowing for the creation of commercial companies which can bring the benefits of their discoveries to the public. Diseases such as Alzheimer’s, Depression, Schizophrenia and many others have a devastating effect on the quality of life of people and those around them. In an advanced society, which takes care of its sick, it also means a huge cost to the economy. Traumatic brain injury has great impact in many areas of present-day life, from battlefield situations to day-to-day injuries resulting from car accidents. Athletic injuries also represent a common cause of mild to serious brain trauma. In the United States, brain diseases impose major medical, social, and financial burdens on people everywhere. One of three Americans is living with a brain-related illness, injury or disease.  The economic burden generated by brain-related illness is estimated to reach $1.3 trillion per year in the U.S. due to healthcare costs and lost income.


Click here to read the whole article


 

BIRD Submission Dates                                                                                     


The following are the upcoming deadlines for submission:


Wednesday, March 14, 2012 Executive Summary of the Proposal 

Tuesday, April 24, 2012 Final Proposal

Board of Governors:
Thursday, June 21, 2012


Deadlines for BIRD Energy will be posted shortly.


 
BIRD Foundation on Facebook

  
 
       
   
 

Join our new Facebook Page and get the latest news about our activities, events and hot topics in the US and Israeli high-tech scenes.



 
Latest Investments

DOE and Israel Announce $3.1 Million in Cooperative Clean Energy Projects – September 26, 2011

The U.S. Department of Energy (DOE) and the Ministry of National Infrastructures of Israel (MNI) have selected four projects to receive $3.1 million under the 2011 Binational Industrial Research and Development (BIRD) Energy program.

To view the press release click here
 

 

BIRD – Israel -US Binational Industrial R&D Foundation Invested $8.1 Million in Nine New Projects   -   July 7, 2011

The approved projects involve innovations in the areas of Life Sciences, Healthcare IT, Electronics, Software and Energy. In addition to the grants from BIRD, the projects will access private sector funding, boosting the total value of all projects to $24 million.


The approved projects involve innovations in the areas of Life Sciences, Healthcare IT, Electronics, Software and Energy. In addition to the grants from BIRD, the projects will access private sector funding, boosting the total value of all projects to $24 million.

To view the press release please click here


 
Spotlight on BIRD Projects


U.S. National Hockey Team wins world championship following collaboration with the Israeli company ACE in which a software based perception and decision making skills product was developed.

USA Hockey, the national governing body for the sport of ice hockey in the United States has recently announced that the U.S. Hockey National Teams have adopted a revolutionary training technology originally developed for Israeli fighter pilots.


This announcement came upon a 2-year collaboration between USA Hockey and ACE Applied Cognitive Engineering Ltd., assisted by the BIRD Foundation. USA Hockey and ACE have developed a ground-breaking product that for the first time ever, provides hockey players with a training tool to develop “hockey sense.”


The program, called The Hockey IntelliGym, is a software-based product that furnishes players with a highly effective training tool to develop perception and decision-making skills. Further, it enables coaches to fine-tune the training program and follow-up on the progress of their players.

 

 

 

 

Click here to read the whole article



 

Axxana and EMC Deliver Zero Data Loss Disaster Recovery to Avago Technologies


In September 2011, Axxana announced that Avago Technologies, a leading supplier of analog interface components for communications, industrial and consumer applications, has purchased the Phoenix System® RP.  

The Phoenix System RP is an unparalleled, cost-effective solution, delivering synchronous replication benefits over asynchronous infrastructure for an affordable price.

Developed in conjunction with EMC RecoverPoint with $950,000 funding from BIRDF, the system received Storage Magazine-SearchStorage.com’s “Product of the Year" Silver Award.

The Axxana system provides significant cost savings by protecting Avago’s data during high load application peaks, which enables Avago to stay with average throughput bandwidth levels for their communication lines. Therefore, Avago can avoid unnecessary costly upgrades to higher bandwidth over time.

Click here to read the whole article

 

BIRD Funded Project Receives US FDA Approval for Drug that Treats Patients with Chronic Gout

The new therapeutic treatment was the result of a BIRD funded project that began in 1998 between the U.S. company, Mountain View Pharmaceuticals, and their Israeli partner, Bio-technology General.

Savient Pharmaceuticals has exclusively licensed worldwide rights to the jointly-developed technology related to KRYSTEXXA and its uses and currently markets the drug worldwide.   

This was the first FDA approved treatment to show significant clinical improvement within six months of therapy. KRYSTEXXA became commercially available in the United States by prescription on December 1, 2010. A recent Phase III study, published in The Journal of the American Medical Association (JAMA) in August, 2011, demonstrates clinical improvement during a six month time period.

Click here to read the whole article


Upcoming Events

Neurotechnology - Training the Brain: Neuroplasticity & the Human Mind
November 1, 2011- Mountain View , CA
The event will provide a unique opportunity to hear from Dr. Michael Merzenich, one of the foremost figures in Neuroplasticity: the brain's powerful ability to change itself and
adapt. 


 

America-Israel Chamber of Commerce

US-Israel Healthcare Information Technology Conference

November 15-16, 2011- Philadelphia



AICC, in partnership with the Jefferson School of Population Health and with support from the BIRD Foundation and the Israel Economic Mission to North America, is holding a full-day program (11/16) that will bring together representatives from Israel’s innovative and advanced healthcare industry with regional stakeholders, to hear from industry experts and explore opportunities for strategic partnership and investment.

The conference gala Kick-Off (11/15) welcoming the Israeli delegation and
celebrating local health care leaders who have fostered collaborations with Israel, will feature keynote speaker, Joseph Frick, Former CEO, Independence Blue Cross.   Select companies will present to investors on November 17th in Lehigh Valley , PA.  



Alternative Finance Conference
December 12-13, 2011 - Tel-Aviv


DealFlow Media's Alternative Finance Conference is a forum for discussion of unconventional sources of capital for Israeli companies. This event transcends familiar dialogue on venture capital and private equity and dives right into the topics that Israeli companies aren't familiar with.

 



BIRD Board of Governors Meeting
December 13, 2011-  Israel

Approval of funding for new projects between Israeli and American Companies


 
PrintTell a friend
Jump to page content